# A Prospective Cohort Study on Warfarin Personalized Medication

> **NCT06428110** · — · COMPLETED · sponsor: **Haobin Li** · enrollment: 272 (actual)

## Conditions studied

- Warfarin Sodium Causing Adverse Effects in Therapeutic Use

## Interventions

- **OTHER:** 

## Key facts

- **NCT ID:** NCT06428110
- **Lead sponsor:** Haobin Li
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-01
- **Primary completion:** 2023-12-12
- **Final completion:** 2023-12-12
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06428110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06428110, "A Prospective Cohort Study on Warfarin Personalized Medication". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06428110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*